Antibiotic treatment of verocytotoxin-producingEscherichia coli(VTEC) infection: a systematic review and a proposal
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibiotic treatment of verocytotoxin-producingEscherichia coli(VTEC) infection: a systematic review and a proposal
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 70, Issue 9, Pages 2440-2446
Publisher
Oxford University Press (OUP)
Online
2015-06-21
DOI
10.1093/jac/dkv162
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Subinhibitory Concentrations of Antimicrobial Agents on Escherichia coli O157:H7 Shiga Toxin Release and Role of the SOS Response
- (2013) Farah J. Nassar et al. Foodborne Pathogens and Disease
- Effects of Antibiotics on Shiga Toxin 2 Production and Bacteriophage Induction by Epidemic Escherichia coli O104:H4 Strain
- (2012) Martina Bielaszewska et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS)
- (2012) Paul N Goldwater et al. BMC Medicine
- Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak
- (2012) Diana Corogeanu et al. BMC MICROBIOLOGY
- Risk Factors for the Hemolytic Uremic Syndrome in Children Infected With Escherichia coli O157:H7: A Multivariable Analysis
- (2012) C. S. Wong et al. CLINICAL INFECTIOUS DISEASES
- Association Between Azithromycin Therapy and Duration of Bacterial Shedding Among Patients With Shiga Toxin–Producing Enteroaggregative Escherichia coli O104:H4
- (2012) Martin Nitschke et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multicenter Evaluation of a Sequence-Based Protocol for Subtyping Shiga Toxins and Standardizing Stx Nomenclature
- (2012) F. Scheutz et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparative Genomics and stx Phage Characterization of LEE-Negative Shiga Toxin-Producing Escherichia coli
- (2012) Susan R. Steyert et al. Frontiers in Cellular and Infection Microbiology
- Origins of theE. coliStrain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany
- (2011) David A. Rasko et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, Minnesota
- (2011) Kirk E. Smith et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Different Classes of Antibiotics Differentially Influence Shiga Toxin Production
- (2010) C. M. McGannon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice
- (2010) Elias A. Rahal et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Primary and secondary cases in Escherichia coliO157 outbreaks: a statistical analysis
- (2009) Kate G Snedeker et al. BMC INFECTIOUS DISEASES
- Effects of Ampicillin, Gentamicin, and Cefotaxime on the Release of Shiga Toxins from Shiga Toxin–Producing Escherichia coli Isolated During a Diarrhea Episode in Faisalabad, Pakistan
- (2009) Mashkoor Mohsin et al. Foodborne Pathogens and Disease
- Effects of fosfomycin on Shiga toxin-producing Escherichia coli: quantification of copy numbers of Shiga toxin-encoding genes and their expression levels using real-time PCR
- (2009) N. Ichinohe et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Subtype-Specific Suppression of Shiga Toxin 2 Released from Escherichia coli upon Exposure to Protein Synthesis Inhibitors
- (2008) M. G. Pedersen et al. JOURNAL OF CLINICAL MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started